HEATHER FURNAS
SANTA ROSA, CA NPI 1164593497
Browse related groups: CA REVANCE THERAPEUTICS, INC. All categories
General Payments — all program years on this page
$5,468.47
- Category: General Payments
- Program years: PY2018–2024
- Record count: 36
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $212.72 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $212.72 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | $125.25 | 4 |
| ABBVIE INC. | $60.66 | 3 |
| Galderma Laboratories, L.P. | $13.44 | 1 |
| MOTIVA USA, LLC | $13.37 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1113834848 | ABBVIE INC. | $19.57 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1113836810 | ABBVIE INC. | $24.44 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1113836818 | ABBVIE INC. | $16.65 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139154798 | MOTIVA USA, LLC | $13.37 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145298462 | Galderma Laboratories, L.P. | $13.44 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147918234 | REVANCE THERAPEUTICS, INC. | $24.17 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147918236 | REVANCE THERAPEUTICS, INC. | $27.58 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147918238 | REVANCE THERAPEUTICS, INC. | $33.48 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147918240 | REVANCE THERAPEUTICS, INC. | $40.02 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.